Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study

Naslov

Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study

Identifikator

/unibl/sci/idNaucniRad:35094
info:doi/doi.org/10.1007/s00210-024-03136-1

Tip

Pronađite slične unoseAcademic Article
Pronađite slične unosetext

Datum

Pronađite slične unose2024-05

Bibliografski citat

P. Kovačević, D. Milaković, T. Kovačević, V. Barišić, S. Dragić, B. Zlojutro, B. Miljković, K. Vučićević, Z. Rizwan, Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study, NAUNYN-SCHMIEDEBERG`S ARCHIVES OF PHARMACOLOGY, Vol. 397, pp. 7747 - 7756, May, 2024

Referenca

https://link.springer.com/article/10.1007/s00210-024-03136-1#Abs1

Početna stranica

7747

Krajnja stranica

7756

Je dio

NAUNYN-SCHMIEDEBERG`S ARCHIVES OF PHARMACOLOGY
0028-1298

Lista autora

Pronađite slične unosePeđa Kovačević
Pronađite slične unoseDragana Milaković
Pronađite slične unoseTijana Kovačević
Pronađite slične unoseVedrana Barišić
Pronađite slične unoseSaša Dragić
Pronađite slične unoseBiljana Zlojutro
Pronađite slične unoseBranislava Miljković
Pronađite slične unoseKatarina Vučićević
Pronađite slične unoseZeeshan Rizwan

Position: 133343 (10 views)